Use access key #2 to skip to page content.
$2.16 -0.03 (-1.37%)
10/7/2008 11:31 AM

Ligand Pharmaceuticals, Inc. (LGND)

CAPS Rating:
**

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.

View All Commentary (LGND)

Recs

0

Avatar ImmortalThanos (< 20) Submitted: 2/28/08 11:26 AM : Underperform Start Price: $3.67 LGND Score: 18.67

Avoid this like the plague. This is another one of those "Jack Of All Trades" companies that never really gets anywhere. Skip this until they get a better mission statement developed.

Report this Post Replies: 0 | Reply

Featured Broker Partners